Work

First-in-human investigation of the oral first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.tps2615

Authors: Andrew Jacob Brenner, Daniel D. Von Hoff, Jeffrey R. Infante, Manish R. Patel, Suzanne Fields Jones, Howard A. Burris, Chris Rubino, William McCulloch, Valentina Zhukova-Harrill, George Kemble

Institutions: The University of Texas at San Antonio Health Science Center, Translational Genomics Research Institute, Sarah Cannon, Tennessee Oncology

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600409591

Cites:

Cited by: 17

Related to: 10